Diamonds and Dogs


Abbott Labs (ABT) gets good news from the FDA. The drug maker is up 6% to all-time highs as The U.S. authorizes emergency use of Abbott's rapid Covid-19 test that costs $5 and takes only 15 minutes. One analyst expects a $750 million boost to Abbott's sales while the travel stocks are all getting a boost.

Becton Dickinson (BDX) lower following earnings. The medical supply maker is down 3% after reporting a mixed bag as sales for Covid-19 diagnostic testing were strong while research-related activity was below pre-Covid levels and sales for procedures were lower due to lower hospital admissions due to Covid-19.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.